The medical cannabis sector is preparing for dizzying growth, projecting to reach almost 100 billion euros by 2030, becoming a promising area in the field of alternative treatments.
The previously restricted medical cannabis industry is experiencing a global renaissance. Since its widespread ban at the end of the 20th century, the scenario is changing dramatically. In 2022, the global medical cannabis market recorded revenues of 15,770 million euros and it is expected that by 2030, this figure will climb to 96,540 million, growing at an interannual rate of 25.4%.
This transformation is due in part to the revision of the classification of cannabis by the World Health Organization in 2019, which has facilitated research and opened the door to regulation by countries. Several regions are progressively adopting laws to regulate its medicinal use, with Portugal and France being notable examples in Europe. However, Spain continues to lag behind in this aspect , still awaiting the publication of regulations expected for November of last year.
